Original articles
J.Pcrinat. Med. 6(1978) . This is based on the assumption that the nutritional insufficiency is caused maintained by a disturbance in the microcirculation due to platelet aggregation and fibrin deposits. By inhibiting these coagulation processes the disturbances of metabolic exchange might be alleviated. Generally, the method has been to admit patients to the hospital and save for some exceptions [1] to administer heparin by constant infusion (20-40,000 lU/day). While this method is rational it has the great disadvantage of requiring long-term hospitalization which even highJy motivated patients are often unable to accept. Based on the experiences with the post-operative prophylaxis of thrombosis with heparin in intermittent low doses subcutaneously we have attempted to treat cases of placental insufficiency in this fashion äs well. We expected these results to be less successful than those with continuous infusions with heparin; the method nevertheless is more practical.
l Material and methods
Thirteen pregnant women with suspected placental insufficiency were admitted between the 29th and 37 th week of gestation. Depending upon their weight they received 5000 units of heparin subcutaneous injection in 8-12 hour intervals. The patients or their husbands learned the injection technique and the further treatment was carried out at home similar to that in diabetics provided that the patient was ready, able and wflling. The therapy was discontinued at term or when the desired therapeutic objective had been obtained. The placental insufficiency was followed by ultrasonography, daily estriol excretion (radio-immunoassay) äs well äs serum estriol and HPL determinations. Coagulation studies were not carried out.
Results
Tab. I summarizes onset and duration of the heparinization and other relevant clinical data. One infant (case 10) died soon after birth because of renal agenesis. The placenta had marked signs of severe insufficiency. Another infant (case 12) died in utero from severe placental insufficiency during the treatment with heparin. Table 2 correlates the birth weight and weight: length ratio with the Standards of NICKL [6] . In retrospect case 2 was probably not placental insufficiency even though the urinary estriol excretion was consistently at 5 mg/24 hours. Possibly case 8 in retrospect was also not a placental insufficiency, however, the patient's history had indicated one. The assessment of the therapeutic success was based on the growth increment of the biparietal diameter äs well äs the increased estriol excretion (see also Figs. l and 2). In six cases the effect of the treatment was satisfactory, in three cases moderate, and in one case the treatment failed not been proven for several reasons. The intrauterine diagnosis of a placental deficiency is very difficult. While there are several methods available, errors in measurement and biological variability are relatively large. On the other hand, the therapeutic effort of a continuous heparinization in the hospital with bed rest is so high that a standardized therapy with larger groups of patients has not been done. The lack of comparable cases even in large hospitals is another reason for the lack of controlled studies. Lastly, the efficacy of heparinization is limited in that a growth retardation or decreased hormonal levels during the existing placental insufficiency has already occurred. Since existing fibrin deposits cannot be dissolved, at best only further deterioration can be prevented. Other factors of placental insufficiency remain uninfluenced, e.g. disturbances in villous maturation, decreased vascularization and other functional pathological factors. LUDWIG [5] demonstrated unequivocally pathologic fibrinization of the utero-placental vascular bed. Thus, increased fibrin deposits may at least in part, participate in the clinical presentation of placental insufficiency. Experiences with continuous heparin treatment [l, 2, 3,4, S] thus far have been equivocal. In selected cases, however, therapy seems to be promising. The principal disadvantage is the continuous infusion requiring hospitalization. Therefore, the initiation of treatment is often delayed and limited. Ambulatory treatment s chosen by us based on the good experiences with the subcutaneous post-operative prophylaxis for thrombosis allows the generous prophylatic use of low dose heparinization when placental insufficiency is suspected. The disadvangage undoubtedly is the possibility for lesser efficacy because of the low doses. In two of our 13 cases a placental insufficiency could retrospectively be excluded. In one case therapy failed because it was started too late and the irreparable placental insufficiency could not be abated. The fetus died in utero during the treatment. In another case of severe placental insufficiency, the infant died post-partum with renal agenesis. Therefore, this case was excluded from the evaluation. The remaining nine cases were predominately successful. In particular the Iongitudinal growth which correlates well with the increase of the biparietal diameter was stimulated while the weight increase in relation to the lon- gitudinal growth remained behind. Consequently, the weight: length ratio in many cases is at a lower percentile than the birth weight (Tab. II). In some cases [l, 12, 13] therapy appears to have been initiated too late and the duration was too short.
This investigation has to be considered äs a pilot study which would be collaborated with larger numbers of patients. Especially we can not yet make any Statements about indications, the limits of the treatment or the possible usefulness of true prophylaxis. Thus far we have used heparinization only in patients with pathological ultrasonographic and hormone findings, i.e. only after some impairment has already occurred. This would be irreversible if fibrin deposits have already occurred. Therefore, the hypothesis of true prophylaxis would have to be tested in cases of placental insufficiency in preceding pregnancies. Lastly, it is not clear whether the dose used in this study is sufficient considering the already present thromboplastin activity with existing placental insufficiency. A prerequisite for. the practical use of outpatient therapy is a practical dose form. Objectives are the smallest possible injection volumes, a reliable standardization, and packaging in a one-way syringe or 5000 unit ampule in order to avoid dosage errors. . r In summary, we believe that intermittent heparinization of outpatients for placental insufficiency has theoretical advantages. This must be based on an early diagnosis with ultrasound measurements and hormone analysis. The therapy has to be initiated even in suspected cases and it can be carried out in our experience by the ambulatory patient herseif or members of her family. This mode of treatment requires adequate planning and cooperation by the patient. For severe cases of placental insufficiency outpatient heparinization is probably inadequate and hospital admission with bed rest and continuous heparinization in higher doses is necessary. With these doses coagulation studies are not necessary. These heparin doses which are below the threshold interfer merely in the early phase or coagulation. By Inhibition of activated factors IX, X, XI they delay the release of thromboplastin. The normal coagulation Status of the blood is quickly re-established so that all other coagulation values are remaining largely in the normal ränge m.
Summary
Treatment of placental insufficiency with heparin is based pn the theory that the nutritive insufficiency is maintained by platelet aggregation and fibrin deposits on the villi and that it might be abated by inhibiting these coagulation processes. In earlier studies about the efficacy of heparin treatments patients have been hospitalized and treated with continuous Infusion of heparin. The results were generally satisfactory. The disadvantage of this mode of treatment is undoubtedly the necessity for hospitalization and continued infusion. This has prevented larger numbers of patients from being studied and therapy is often begun late. Based on the good experiences with post-operative thrombosis prophylaxis by low dose heparinization we have attempted to treat placental insufficiency with the same doses in outpatients. Patients were admitted initially when placental insufficiency was suspected and depending on their weight received two to three times daily 5000 units of heparin subcutaneously. After being trained in the injection technique treatment was continued by the patient or her husband at home. The diagnosis of placental insufficiency and the further course was monitored with ultrasonography, urinary estriol excretion and the determination of HPL and estriol in the serum. The study comprises 13 patients. The successful treatment was best indicated in the increasing growth of the biparietal diameter which was noticable above the expected level. Similarly the 24 hour urinary estriol excretion increased at times more than was expected from the course of the pregnancy. In contrast the monitoring with serum estriol and serum HPL were less satisfactory. Our results were fairly encouraging. In some cases therapy began too late, lasted too briefly or remained unsuccessful. A prerequisite for a successful treatment with ambulatory low dose heparinization is the early or even prophylactic use of therapy in suspected cases of placental insufficiency and the consistent long-term treatment. In severe cases of placental insufficiency the patient should be hospitalized and the heparin given by continuous infusion in higher doses.
On the other band one should not have too high expectations from this mode of treatment since undoubtedly the Inhibition of placental coagulation processes represent only a partial solution of the problern of placental insufficiency.
Additional important factors for this therapy are the understanding and cooperation of the patient äs well äs the availability of suitable heparin dose forms from the pharmaceutical industry. A small injection volume with a standardized content of 5000 units in a one-way syringe or one dose ampule is desirable.
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In our experience and those of other coagulation studies during the treatment are generally not necessaiy. 
Zusammenfassung

Ambulante Heparinisierung bei Placentainsuffizienz
Die Behandlung der Placentainsuffizienz mit Heparin gründet sich auf die Vorstellung, daß die nutritive Insuffizienz durch Thrombozytenaggregationen und Fibrinablagerungen an den Zotten unterhalten werde und durch eine Hemmung dieser Gerinnungsabläufe behoben werden könnte. In früheren Untersuchungen über die Effektivität der Heparinbehandlung wurden die Patientinnen hospitalisiert und mit Dauerinfusionen von heparinhaltigen Lösun-gen behandelt. Die mitgeteilten Erfolge waren im allgemeinen befriedigend. Der größte Nachteil dieser Behandlungsform ist zweifellos die Notwendigkeit der Krankenhausaufnahme und Infusionsdauerbehandlung. Durch diesen überhöhten therapeutischen Aufwand werden größere Untersuchungsreihen verhindert und die Therapie im allgemeinen zu spät eingesetzt. Ausgehend von den guten Erfahrungen mit der post
